PE
Peyton
User·

INKW (Greene Concepts) Stock Financial Metrics: A Real-World Walkthrough

Summary: This article breaks down the key financial metrics that characterize INKW (Greene Concepts Inc.) stock—including revenue, profit, debt, and vital ratios. We’ll walk through locating real data, interpreting numbers, and even dig into the slippery realities of penny stocks. I’ll use a hands-on approach (screenshots and all), share personal mishaps, and sprinkle in real industry insight, so that even if you’re new to financial statements or just poking around OTC stocks, you’ll find the answers (and probably a cautionary tale or two).

What Problem Are We Solving?

Ever looked up a company like INKW—maybe for that “hidden gem” feeling—and struggled to find trustworthy, concrete financials? That was me, squinting at green bars on sites with 15 pop-ups, or wondering why some numbers felt made up. The truth is, with penny stocks (INKW trades OTC under “Greene Concepts Inc.”) reliable details are rare. So, I set out to chase the official numbers—so you don’t have to—and show you exactly how to read (and question) them.

Step 1: Where to Grab INKW Financials (And Why It’s Tricky)

First, unlike companies on NASDAQ or NYSE, OTC stocks like INKW aren’t required to file reports with the SEC unless they voluntarily do so. You won’t find them on EDGAR most of the time. Instead, most investors (me included) check for filings on the OTC Markets site. See my screenshot below if you’re lost (I make this mistake at least once a year, opening EDGAR then remembering, oops, this is an OTC Pink stock).

INKW Disclosure on OTC Markets

Step 2: Key Metrics—What Do INKW Numbers Say?

Financial health for any stock comes down to four pillars: revenue, profit/loss, debt/equity, and key ratios (think current ratio, net margin). INKW, being a micro-cap bottling and water company, is a textbook example of volatility—and, frankly, risk.

  • Revenue: According to their last annual report (FYE July 31, 2023), INKW reported annual sales (revenue) of $1,042,130. It’s growing (up from $660k in 2022), but small by any standard.
  • Net Profit/Loss: Net income for 2023 came in at -$1,138,642 (yep, a net loss higher than their revenue). In tiny caps, operating losses are honestly expected, but you can see how growth is still an aspiration, not a present reality.
  • Debt: Total liabilities on the balance sheet were reported at $2,892,856. Most of it was convertible notes and short-term debt, a classic penny stock structure. No surprise, but it’s a red flag for solvency.
  • Assets: Total assets stood at $3,843,451, mostly inventory and property (their bottling plant).
  • Current Ratio: Total current assets were $381,711, current liabilities $2,892,856. So, current ratio is ~0.13 (well below the healthy “1” mark) -- which practically means if every creditor showed up today, INKW’s cash and near-cash couldn’t cover even a fraction.
  • Gross Margin: Gross profit was $583,929, so gross margin is about 56%. Not bad (water’s cheap), but it can be misleading if fixed costs balloon.
  • Net Margin: -109% for 2023. (Negative because the loss exceeded sales.)

Here’s an “oops” moment: in my first attempt pulling the numbers, I accidentally used a Q2 quarterly statement, which undercounted revenue. Always double-check you’ve got the latest fiscal year! (Been burned by old filings on “pink current” stocks myself.)

Step 3: Peeking Under the Hood—Can These Metrics Be Trusted?

With INKW, all numbers above come from “unaudited” OTC filings—not the gold standard. OTC Markets makes this clear: always check for the Unaudited flag in the upper right. Some companies fudge timelines, or even recycle old data. If you want “audited” financials, you’re in the wrong neighborhood!

INKW Quarter Flagged as Unaudited

Verified Trade Data: US vs. EU (Just for Kicks)

Here’s a fun detour. Did you know that trade and accounting standards—how “verified” is defined—vary widely by jurisdiction? For instance, the US has SEC requirements, while the EU uses a different system (see ESMA). “Pink Current” OTC companies like INKW are essentially trusting the company itself to self-certify.

Jurisdiction Verified Trade Standard Legal Authority Accrediting Agency
USA (SEC Reporting) GAAP/Audited Statements Securities Exchange Act 1934 SEC, PCAOB
EU public cos (ESMA/IAS) IFRS/Audited Statements IAS Regulation (EC) No 1606/2002 ESMA, national FSAs
US OTC Pink Unaudited, self-disclosed, minimal review Rule 15c2-11, FINRA OTC Markets Group

A True-World Example: Certifying “Verified Revenue” Across Borders

Let’s conjure an example: an American distributor (A Corp) wants to buy INKW’s “Be Water” for a big retail push, but needs verified sales data for compliance. When A Corp asks for “audited statements,” INKW hands over its OTC unaudited report. The compliance officer at A Corp, familiar with SEC and PCAOB requirements, immediately flags this as insufficient—she needs a CPA letter or PCAOB-audited documents (see actual compliance requirements on the Securities Exchange Act).

If A Corp’s trade partner was an EU firm (B BV), they’d want IFRS-audited statements. Here, B BV’s legal team might call out the lack of external validation, and demand a third-party review. In both cases, INKW’s data isn’t “verified” by global standards—just self-reported.

Industry Insight: As compliance expert Dr. L. Reece (quoted in the KPMG guide) put it: “Without third-party attestation, numbers — especially from microcaps — are treated with skepticism by regulators and counterparties globally.”

Here’s How I Attempted My Own INKW Due Diligence

Early on, I tried checking INKW’s numbers against competitors—say, Primo Water (PRMW, NYSE-listed). You instantly see the difference: audited 10-K vs. three-page “Unaudited Annual Disclosure.” Once, I misread total equity as “income,” leading to a wildly optimistic view of INKW’s value. Lesson learned: penny stock filings require patience — and deep skepticism.

Wrapping Up: What INKW’s Financials Tell Us (and Next Steps)

INKW’s key financials show a tiny, growing business—but one with heavy losses, mounting debt, and very little real verification behind the numbers. If you’re new to analyzing these stocks, be careful: unaudited data means caveats everywhere. For investors or trade partners needing “verified” trade levels, these numbers won’t meet global or US standards without outside review. My advice? Use INKW filings for a general sense of trends, but don’t trust them with your savings or compliance requirements unless you see PCAOB or equivalent assurance.

For your next steps: always fact-check on OTC Markets, verify the “audited” status, and benchmark PTO-style companies against regulator standards (SEC, ESMA, etc.). If you’re considering an investment or a trade, demand an externally verified statement, and if you don’t get one…walk away.

Got another penny stock on your radar? Share your findings, or horror stories — we learn more comparing real experiences than numbers alone. And remember, even pros get tripped up by OTC data sets!

References & Further Reading

Add your answer to this questionWant to answer? Visit the question page.